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functionality of NOS in RBCs remain to be elucidated. Mass spectro-
metry is the key analytical tool in this endeavor.
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Response to commentary
Miriam M. Cortese-Krott, Malte Kelm
In our article [1] we discussed the history of detection,
unequivocal identiﬁcation by enzymatic and analytical techniques
including electrospray ionization tandem mass spectrometry (ESI-
MS/MS), and potential pathophysiological signiﬁcance of red cell
eNOS, i.e. nitric oxide synthase isoform 3, or "endothelial" isoform
carried by red blood cells (RBCs), and put forward the hypothesis
that red cell eNOS may play a role in the signaling and function of
RBCs and possibly cardiovascular pathophysiology.
As pointed out by Dr. Tsikas in his current letter to the Editor of
Redox Biology, his group never investigated the occurrence of
NOS/eNOS protein in RBC; rather, he reported on the capacity of
RBC suspensions or lysates to convert L-15N-arginine into 15N-
nitrate. These results were published in a Letter to Blood in May
2012 [2], which to the best of our knowledge is the only publica-
tion to date that presented data related to the enzymatic conver-
sion of L-15N-arginine to 15N-nitrate in RBC. Those results show
that (A) suspensions of RBC (from 1 blood donor) take up 15N
arginine in the presence and absence of glucose (Fig. 1A); B) the
ratios of 15N/14N-nitrite and 15N/14N-nitrate, in an RBC suspension
(from 1 blood donor), do not differ at all (nitrite) or increase only
marginally (nitrate) when cells were incubated with 0.4 mM
L-15N-arg at 37°C for 20 min (Fig. 1B); C) addition of 5 mM
L-15N-arg to RBC lysates (from EDTA blood of 5 donors) - the ratio
of 15N/14N nitrate did not change with time (Fig. 1C) whereas the
ratio changed from 0.008 to 0.012 after addition of 50 µg/ml
recombinant human eNOS (Fig. 1C).
Thus, these results seem to demonstrate that addition of 15N-L-
arginine does not affect the 15N/14N-nitrate ratio, and that even the
addition of excess recombinant eNOS increases these ratios only
by 1.5 fold, failing to increase further with time. Considering that
the commercial recombinant eNOS enzyme preparation used has
an activity of at least 125 U/mg (http://www.enzolifesciences.com/
ALX-201-853/enos-human-recombinant/), and that the amount of
enzyme added was 50 µg/ml, this should have resulted in a speciﬁc
activity of at least 6.25 nmoles NO/ml/min or an NO yield of 187.5
nmoles/ml (i.e. µM) over a 30 min incubation period. It is surpris-
ing that the addition of such signiﬁcant amounts of recombinant
eNOS to RBC lysates increased the 15N/14N-nitrate ratio only
1.5 fold, and failed to increase this ratio beyond 20 min of
incubation. Thus, either NOS cofactors were severely limited
and/or the method of detection of the NOS products was not very
sensitive in this matrix. Now considering that in our and other
investigators' hands both the amount of protein, and its activity is
low (e.g. [1,3–9], it would not be expected that the method
proposed by Dr. Tsikas was indeed able to detect differences in
ratios between 15N/14N-nitrate in RBC lysates or in the supernatant
of these cells. In previous work by ourselves and other labora-
tories, the activity of the enzyme was assessed by analyzing the
NOS-dependent conversion of L-3H-arginine, 14C-arginine or 15N-
arginine to the corresponding L-citrulline and by functional assays.
The speciﬁcity of the measurements was controlled (1) by using
NOS inhibitors [6,9]}; (2) by omitting Ca++/CaM in the reaction
buffer [6] or adding EDTA [4] or (3) by using RBC frommice lacking
eNOS [7,10] - all controls needed for validating any technique
aiming at investigating NOS activity.
Regarding the criticism about the "alleged chemistry" of the
NO/nitrite and nitrate equilibria in human RBCs (without con-
sidering of course S-nitrosothiols [11]), we invite Dr. Tsikas to
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propose mechanisms amenable to experimentation in the RBC. We
and many others in the NO ﬁeld are still trying to understand the
biochemical events which are involved in heme-dependent NO/
nitrite/nitrate metabolism (e.g. [12,13]), what roles enzymes such
as xanthine oxidoreductase and carbonic anhydrase play in nitrite/
nitrate reduction [5,14,15], what role anion transporters [16] and
even sulﬁde [17] may play in these equilibria.
Clearly an approach with one technique alone has its limita-
tions, irrespective of its level of sophistication, and likely be
insufﬁcient to describe and fully elucidate these equilibria. In
contemporary science it is rarely what one is "convinced" of or
what is "analytically easily accessible" that provides an incremen-
tal change in conceptual understanding or a real breakthrough;
rather, it is the combination of multi-level analytical, genetic and
pharmacological approaches, in a truly integrated effort encom-
passing varied expertise from different laboratories, that will
ultimately deliver results that may reveal the truth about nitric
oxide metabolism in RBC and its role in physiology and pathophy-
siology. Stay tuned as others join in to unveil the role of NO in
regulating blood cell function.
Sincerely,
Miriam M. Cortese-Krott & Malte Kelm
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